Steven Immergut | SVP, Head of Corporate Communications and IR |
Dr. Ted Love | President and Chief Executive Officer |
Jeff Farrow | Chief Financial Officer |
David Johnson | Chief Commercial Officer |
Dr. Kim Smith Whitley | EVP and Head of R&D |
Alethia Young | Cantor Fitzgerald |
Akash Tewari | Wolfe Research |
Lyla Youssef | Cowen & Company |
Xinyue Lu | RBC Capital Markets |
Jason Gerberry | Bank of America |
Andreas Argyrides | Wedbush Securities |
Danielle Brill | Raymond James |
Yanan Zhu | Wells Fargo |
Paul Choi | Goldman Sachs |
Yatin Suneja | Guggenheim Partners |
Matthew Harrison | Morgan Stanley |
Joon So Lee | Truist Securities |
Samantha Corwin | William Blair |
Greetings, and welcome to the Global Blood Therapeutics Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow prepared remarks. [Operator instructions] As a reminder, this conference is being recorded. I would now like to turn the call over to Steven Immergut.